Serum 8-isoprostane levels in patients with resistant oral lichen planus before and after treatment with lycopene: a randomized clinical trial
Abstract Background Oral lichen planus is an autoimmune disease in which topical steroids are the first line of treatment. The adverse effects of systemic corticosteroids prescribed for resistant oral lichen planus cases advocate alternative modalities. Lycopene is an antioxidant with a wide range o...
Main Authors: | Aliaa Abdelmoniem Bedeir Eita, Azza Mohamed Zaki, Sabah Abdelhady Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | BMC Oral Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12903-021-01711-z |
Similar Items
-
Evaluation of the efficacy of lycopene in the management of oral lichen planus: a pilot randomized clinical trial
by: Fateme Arbabi-Kalati, et al.
Published: (2017-12-01) -
Lycopene in the management of oral lichen planus: A placebo-controlled study
by: Nisheeth Saawarn, et al.
Published: (2011-01-01) -
Evaluation of Salivary 8-Isoprostane in Oral Lichen Planus: Case Control Study
by: Asha Sicily Dinesan, et al.
Published: (2020-01-01) -
Lichen Planus Pigmentosus Inversus: A Rare Subvariant of Lichen Planus Pigmentosus
by: Anne Guertler, et al.
Published: (2021-07-01) -
Lichen planus
by: Meng-yu Xie, et al.
Published: (2023-01-01)